Calcineurin inhibitors in the treatment of primary focal segmental glomerulosclerosis: A protocol of systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Evidence suggesting a role for including calcineurin inhibitors(CNIs) in early therapy remains limited for low quality and mainly based on small observation cohort study. We will conduct a systematic reviews to explore the effect and adverse effect of calcineurin inhibitors compared with...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Guozhong, Wang, Xinbin, Li, Shuwen, Dai, Enlai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850689/
https://www.ncbi.nlm.nih.gov/pubmed/33530282
http://dx.doi.org/10.1097/MD.0000000000024533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850689/
https://www.ncbi.nlm.nih.gov/pubmed/33530282
http://dx.doi.org/10.1097/MD.0000000000024533

Ejemplares similares